←Back to Expert Scholars
Translational Medicine / 转化医学Bispecific Antibodies, Lymphoma
Alex Herrera
MD
🏢City of Hope🌐USA
Chief, Division of Lymphoma
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Alex Herrera chairs lymphoma at City of Hope and has led pivotal bispecific antibody trials in diffuse large B-cell lymphoma. He has defined sequencing strategies between CAR-T and bispecifics in relapsed disease. His work shapes modern lymphoma treatment algorithms.
Share:
🧪Research Fields 研究领域
bispecific antibodies
DLBCL
Hodgkin lymphoma
CAR-T vs bispecific sequencing
relapsed lymphoma
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Alex Herrera 的研究动态
Follow Alex Herrera's research updates
留下邮箱，当我们发布与 Alex Herrera（City of Hope）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment